Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Saatchi & Saatchi Consumer Healthcare has landed creative duties on Boniva, a new osteoporosis drug from Hoffmann-LaRoche and GlaxoSmithKline, after a review, sources said.
Billings have not be determined but competing drug Fosamax last year spent more than $50 million on ads, per Nielsen Monitor-Plus. Fosamax is marketed by Merck & Co.
Other contenders for Boniva’s direct-to-consumer account included WPP Group’s Ogilvy & Mather, Interpublic Group’s McCann HumanCare and Havas’ Euro RSCG MVBMS Partners, all in New York, according to sources.
Saatchi
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in